Comparative Biosciences
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
786 Lucerne Dr, Sunnyvale, California, 9...Phone Number
(408) 738-9260Website
www.compbio.comRevenue
$7.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Comparative Biosciences
Comparative Biosciences, Inc. (CBI) specializes in preclinical toxicology and pharmacokinetics services, offering efficacy studies tailored for the biomedical and biopharmaceutical sectors. Their expertise spans various therapeutic areas including dermatology, ophthalmology, oncology, and cardiovascular diseases. CBI is accredited by AAALAC and registered with regulatory bodies such as the FDA and USDA, ensuring high standards in their research practices. The company aims to support drug discovery programs from target discovery through to clinical trial management.Explore more
Comparative Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Comparative Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Comparative Biosciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Comparative Biosciences has new funding data
Congratulate Masked Content for being promoted to Masked Content at Comparative Biosciences
Earning: See what the market has to say on Comparative Biosciences recently announced quarterly report
Comparative Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Comparative Biosciences launches new products
Check out if Comparative Biosciences is spiking on competitors!
Check if Comparative Biosciences has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Comparative Biosciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to Comparative Biosciences
Compare insights from companies similar to Comparative Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Comparative Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Comparative Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Comparative Biosciences.
Comparative Biosciences financials insights
Gather financial insights about Comparative Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Comparative Biosciences Tech Stack
A closer look at the technologies used by Comparative Biosciences
See more technologies
Comparative Biosciences News & Media
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Comparative Biosciences
Sign Up For FreeTo access detailed company insights
Comparative Biosciences, Inc. (CBI) specializes in preclinical toxicology and pharmacokinetics services, offering efficacy studies tailored for the biomedical and biopharmaceutical sectors. Their expertise spans various therapeutic areas including dermatology, ophthalmology, oncology, and cardiovascular diseases. CBI is accredited by AAALAC and reg... Read More
